Blocking cancer-specific mutations in leukemia and brain tumors
| 05-30-2017
© Stefan Pusch/DKFZThe substitution of a single amino acid in a metabolic enzyme can be the cause of various types of cancer. Scientists from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, collaborating with Bayer AG, have now been able to develop a candidate for an agent that is intended to specifically block the altered enzyme. First studies in mice have demonstrated preclinical effects of this investigational compound. …
Related Videos
Recommended
Popular
ALS neuron damage reversed with new compound 02-23-2021 
New study gives the most detailed look yet at the neuroscience… 03-02-2021 
Immunotherapy drug delays onset of type 1 diabetes in at-risk group 03-03-2021 
Two daily servings of fruit and three of vegetables optimal… 03-01-2021 
Injectable hydrogel could help repair heart muscle after a… 03-01-2021